Edwards Lifesciences was incorporated in Delaware in 1999.
Please refer to our company Fact Sheet that is updated quarterly.
Edwards Lifesciences' headquarters are located in Irvine, California. The company has sales and manufacturing offices located throughout the world.
Edwards Lifesciences' facilities are primarily used for business purposes only and are not open to the public. Each year, we welcome all of our shareholders to the Annual Meeting of Stockholders which is typically held at our Irvine facility. Notice of the meeting, which is usually held in May, is included in the company's proxy statement.
We believe that we are a leading global competitor in each of our product lines. In Transcatheter Aortic Valve Replacement, our primary competitors include Medtronic PLC and Boston Scientific Corporation. In Surgical Structural Heart, our primary competitors include Medtronic PLC, Abbot Laboratories, and LivaNova PLC. In Critical Care, we compete primarily with a variety of companies in specific product lines including ICU Medical, Inc., PULSION Medical Systems SE, a subsidiary of Getinge AB, and LiDCO Group PLC. In Transcatheter Mitral and Tricuspid Therapies, our primary competitor is Abbott Laboratories, although there are a considerable number of large and small companies with development efforts in these fields.